Hypogammaglobulinemia in pediatric ICU patients

Related Experiment Video

Updated: Aug 25, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

Saif Rehman1, Daniel Bytnar, John W Berkenbosch

  • 1Departments of Child Health and Anesthesiology, Division of Pediatric Critical Care/Pediatric Anesthesiology, University of Missouri, Columbia, Missouri 65212, USA.

Journal of Intensive Care Medicine
|March 24, 2004
PubMed

Insights

Low immunoglobulin G (IgG) levels were common in pediatric ICU patients, affecting younger, lighter children. However, low IgG did not increase mortality risk in this retrospective study.

Area of Science:

  • Pediatric critical care medicine
  • Immunology
  • Clinical research

Background:

  • Low immunoglobulin G (IgG) levels can impact immune function.
  • The prevalence and clinical significance of hypogammaglobulinemia in pediatric intensive care unit (PICU) populations are not well-defined.

Purpose of the Study:

  • To retrospectively analyze the incidence and characteristics of low IgG levels in a pediatric ICU population.
  • To compare outcomes between patients with and without low IgG levels.

Main Methods:

  • Retrospective chart review of pediatric ICU patients over a 12-month period.
  • Measurement and comparison of IgG levels between patients.
  • Analysis of demographic data (age, weight) and mortality risk.

Main Results:

  • 14 out of 20 (70%) pediatric ICU patients had low IgG levels.
  • Patients with low IgG were younger and had lower body weight compared to those with normal IgG.
  • No significant difference in mortality risk was observed between the low IgG and normal IgG groups.
  • In patients with low IgG, levels ranged from 33% to 99% of age-normal, with 4 patients below 50% of normal.

Conclusions:

  • Low IgG levels are prevalent in pediatric ICU patients.
  • Younger age and lower weight are associated with low IgG in this population.
  • Further prospective studies are required to establish the incidence, impact on survival, and optimal therapeutic strategies for low IgG in pediatric ICUs.

More Related Videos

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis06:27

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis

Published on: January 2, 2017

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...